108 related articles for article (PubMed ID: 2867472)
1. Methamphetamine: toxicity to dopaminergic neurons.
Seiden LS
NIDA Res Monogr; 1985; 62():100-16. PubMed ID: 2867472
[No Abstract] [Full Text] [Related]
2. Influence of supidimide on brain neurotransmitter systems of rats and mice.
Hennies HH; Günzler WA; Flohé L
Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
[TBL] [Abstract][Full Text] [Related]
3. Fetal exposure to methamphetamine in utero stimulates development of serotonergic neurons in three-dimensional reaggregate tissue culture.
Won L; Bubula N; Heller A
Synapse; 2002 Feb; 43(2):139-44. PubMed ID: 11754494
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Abekawa T
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
[TBL] [Abstract][Full Text] [Related]
5. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
Scatton B
Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783
[No Abstract] [Full Text] [Related]
6. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat.
Wallace TL; Gudelsky GA; Vorhees CV
Synapse; 2001 Jan; 39(1):1-7. PubMed ID: 11071703
[TBL] [Abstract][Full Text] [Related]
7. Effects of 2-and/or 5-methylated analogues of 6-hydroxydopamine on norepinephrine-and dopamine-containing neurons.
Liang YO; Adams RN
Mol Pharmacol; 1977 Sep; 13(5):805-18. PubMed ID: 895717
[No Abstract] [Full Text] [Related]
8. [Biochemical studies on tienocarbine and related compounds].
Schöllnhammer G; Seidel PR; Dell HD
Arzneimittelforschung; 1984; 34(10):1254-8. PubMed ID: 6083796
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
11. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
Akiyama K; Sato M; Kashihara K; Otsuki S
Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
[TBL] [Abstract][Full Text] [Related]
12. Tissue culture model for studying MPTP toxicity to dopamine neurons.
Mytilineou C; Cohen G
Adv Neurol; 1987; 45():145-8. PubMed ID: 3493622
[No Abstract] [Full Text] [Related]
13. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Itzhak Y; Martin JL; Ali SF
Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of methamphetamine-induced nigrostriatal dopaminergic neurotoxicity in mice by lipopolysaccharide pretreatment.
Lin YC; Kuo YM; Liao PC; Cherng CG; Su SW; Yu L
Chin J Physiol; 2007 Apr; 50(2):51-6. PubMed ID: 17608141
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
16. Dopamine and norepinephrine in the gastrointestinal tract of mice and the effects of neurotoxins.
Eaker EY; Bixler GB; Dunn AJ; Moreshead WV; Mathias JR
J Pharmacol Exp Ther; 1988 Feb; 244(2):438-42. PubMed ID: 3126292
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
Kawasaki T; Ishihara K; Ago Y; Nakamura S; Itoh S; Baba A; Matsuda T
Eur J Pharmacol; 2006 Aug; 542(1-3):92-9. PubMed ID: 16784740
[TBL] [Abstract][Full Text] [Related]
18. Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.
Snyder SH
Biol Psychiatry; 1970 Oct; 2(4):367-89. PubMed ID: 4320227
[No Abstract] [Full Text] [Related]
19. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
Albers DS; Sonsalla PK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-containing small intensely fluorescent cells and sympathetic ganglion function.
Neff NH; Karoum F; Hadjiconstantinou M
Fed Proc; 1983 Oct; 42(13):3009-11. PubMed ID: 6137420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
